WebDec 31, 2024 · Annual Financial Statements of BioNTech SE, Mainz, December 31, 2024. In case of deviations of the English version of this document from the German version, the German version shall prevail. Statements of Financial Position. 2. … WebMar 30, 2024 · In 2024, the annual profit of biotech company BioNTech SE was around 9.4 billion euros, compared to around 10.3 billion euros in the previous year. This statistic …
BioNTech profits soar as Covid vaccine demand surges
WebMay 4, 2024 · BioNTech has a licensing agreement with the N.I.H., and Pfizer is piggybacking on that license. Pfizer has kept the profitability of its vaccine sales opaque. … WebFeb 2, 2024 · Costs and profits are split 50/50 with BioNTech. Albert Bourla, Pfizer’s chief executive, said it was an “increasingly probable scenario” that people will require boosters, or different ... great learning online jobs
Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine
WebFeb 10, 2024 · BioNTech will share profits from sales of the vaccine - now known as Comirnaty - 50:50 with Pfizer, and also has a 34%-40% profit share agreement in place with Fosun Pharma for distribution in China. WebMar 27, 2024 · Looking ahead for fiscal 2024, estimated BioNTech COVID-19 vaccine revenues would be around 5 billion euros. BioNTech said the revenue estimate reflects expected revenues related to its share of gross profit from COVID-19 vaccine sales in the collaboration partner's territories, and from direct COVID-19 vaccine sales to customers … WebGross profit from the revenue is split 50/50 with BioNTech. Pfizer guidance for their income before tax (after splitting profit with BioNTech) is ‘High-20s as a Percentage of Revenues.’ A conservative 25 percent margin would bring Pfizer’s profit before tax to $9 billion in 2024 from the Comirnaty COVID-19 vaccine. flo health pregnancy